已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

佐剂 免疫系统 埃利斯波特 接种疫苗 抗体 体液免疫 病毒学 免疫学 生物 记忆B细胞 免疫 B细胞 T细胞
作者
Sandra L. Giannini,Emmanuel Hanon,Philippe Moris,Marcelle Van Mechelen,Sandra Morel,Francis Dessy,Marc Fourneau,Brigitte Colau,JoAnn Suzich,Genevieve Losonksy,Marie-Thérèse Martin,Gary Dubin,Martine Wettendorff
出处
期刊:Vaccine [Elsevier BV]
卷期号:24 (33-34): 5937-5949 被引量:458
标识
DOI:10.1016/j.vaccine.2006.06.005
摘要

An effective virus-like particle (VLP) based prophylactic vaccine designed to protect against persistent infection with human papillomavirus (HPV) types 16 and 18 and subsequent lesion development will need to induce a strong humoral and cellular immune response capable of providing long-term protection. Our objective was to evaluate the ability of an HPV16/18 L1 VLP vaccine formulated with the AS04 adjuvant system (3-O-desacyl-4′-monophosphoryl lipid A (MPL) and aluminium salt) to induce an immune response of higher magnitude and persistence compared to a vaccine formulated with aluminium salt only. We demonstrated that MPL adsorbed onto aluminium salt retains its capacity to activate an innate immune response as assessed by the production of TNFα by human monocytes (U937). In addition, vaccination of mice, monkeys or human subjects with AS04 formulations induced higher total anti-L1 VLP16 and L1 VLP18 antibody responses (1.6–8.5-fold) than the aluminium salt only formulations. The enhanced antibody response induced by the AS04 vaccine formulation (1.6–4.1-fold) in monkeys and humans was shown to be targeted to functional neutralising L1 VLP16 and L1 VLP18 epitopes as assessed by V5/J4 specific ELISAs or HPV16 and HPV18 pseudo-neutralization assays. The enhanced immune profile observed with the AS04 formulation in terms of both total, V5/J4 specific and neutralizing antibodies was shown to persist for at least 3.5-year post-vaccination in human subjects. Finally, using the newly developed B cell ELISPOT assay we also demonstrated that the AS04 formulation elicited an increased frequency (2.2–5.2-fold) of HPV L1 VLP specific memory B cells when compared with the aluminium salt only formulations. These data strongly support the role of the AS04 adjuvant, which includes the immunostimulant MPL, in triggering a persistent vaccine-induced immune response of high quality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai应助认真的寒香采纳,获得10
4秒前
5秒前
5秒前
FuuKa完成签到,获得积分10
5秒前
小马甲应助缪缪采纳,获得10
5秒前
5秒前
cdercder应助Q_y采纳,获得10
6秒前
6秒前
Remua发布了新的文献求助10
9秒前
9秒前
babao发布了新的文献求助30
9秒前
朴实夏波完成签到,获得积分10
10秒前
11秒前
仰望星空扭到腰完成签到,获得积分10
12秒前
桐桐应助香山叶正红采纳,获得10
12秒前
希望天下0贩的0应助222采纳,获得10
13秒前
14秒前
zyj发布了新的文献求助10
14秒前
77完成签到 ,获得积分20
14秒前
sun发布了新的文献求助10
16秒前
16秒前
英姑应助scwang采纳,获得30
17秒前
千俞完成签到 ,获得积分10
18秒前
19秒前
花露水完成签到,获得积分20
19秒前
20秒前
21秒前
zzz完成签到 ,获得积分10
23秒前
CipherSage应助lemon采纳,获得10
24秒前
24秒前
奇数页完成签到,获得积分10
24秒前
CYJ发布了新的文献求助10
24秒前
秋作完成签到 ,获得积分10
25秒前
烟花应助Remua采纳,获得10
25秒前
awa606发布了新的文献求助10
26秒前
华仔应助缪缪采纳,获得10
26秒前
酷波er应助LMX采纳,获得10
26秒前
俊逸忆霜发布了新的文献求助50
27秒前
科研通AI6.4应助YS采纳,获得10
28秒前
molihuakai应助1412yz采纳,获得10
28秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Arthritis and Related Conditions, An Issue of Orthopedic Clinics 1000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7288943
求助须知:如何正确求助?哪些是违规求助? 8908564
关于积分的说明 18855077
捐赠科研通 6957389
什么是DOI,文献DOI怎么找? 3208986
关于科研通互助平台的介绍 2378720
邀请新用户注册赠送积分活动 2184758